600252 中恒集团
已收盘 01-09 15:00:00
资讯
新帖
简况
每周股票复盘:中恒集团(600252)获土地收储欠款727.89万元
证券之星 · 03:00
每周股票复盘:中恒集团(600252)获土地收储欠款727.89万元
中恒集团(600252)披露为控股子公司中恒中药材提供担保公告,1月5日股价上涨1.09%
证券之星 · 01-05
中恒集团(600252)披露为控股子公司中恒中药材提供担保公告,1月5日股价上涨1.09%
每周股票复盘:中恒集团(600252)拟清算医药投资基金
证券之星 · 01-02
每周股票复盘:中恒集团(600252)拟清算医药投资基金
中恒集团:为控股子公司提供近1000万元担保
视频滚动新闻 · 2025-12-31
中恒集团:为控股子公司提供近1000万元担保
中恒集团(600252)披露关于变更持续督导财务顾问主办人的公告,12月31日股价上涨0.37%
证券之星 · 2025-12-31
中恒集团(600252)披露关于变更持续督导财务顾问主办人的公告,12月31日股价上涨0.37%
每周股票复盘:中恒集团(600252)拟注销1106.53万股限制性股票
证券之星 · 2025-12-28
每周股票复盘:中恒集团(600252)拟注销1106.53万股限制性股票
中恒集团(600252)披露为控股子公司田七家化提供担保,12月23日股价下跌1.74%
证券之星 · 2025-12-23
中恒集团(600252)披露为控股子公司田七家化提供担保,12月23日股价下跌1.74%
中恒集团(600252)披露股权激励限制性股票回购注销实施公告,12月22日股价下跌0.69%
证券之星 · 2025-12-22
中恒集团(600252)披露股权激励限制性股票回购注销实施公告,12月22日股价下跌0.69%
中恒集团最新公告:控股孙公司获得医疗器械注册证
中金财经 · 2025-12-10
中恒集团最新公告:控股孙公司获得医疗器械注册证
中恒集团(600252)披露控股孙公司获得药物临床试验批准通知书,12月04日股价下跌1.0%
证券之星 · 2025-12-04
中恒集团(600252)披露控股孙公司获得药物临床试验批准通知书,12月04日股价下跌1.0%
中恒集团最新公告:控股孙公司纳米炭铁混悬注射液药物临床试验获批
证券之星 · 2025-12-04
中恒集团最新公告:控股孙公司纳米炭铁混悬注射液药物临床试验获批
异动快报:中恒集团(600252)11月26日9点49分触及涨停板
证券之星 · 2025-11-26
异动快报:中恒集团(600252)11月26日9点49分触及涨停板
中恒集团(600252)2025年三季报简析:营收净利润同比双双增长
证券之星 · 2025-11-01
中恒集团(600252)2025年三季报简析:营收净利润同比双双增长
中恒集团最新公告:控股子公司莱美药业产品尼可地尔片拟中选第十一批全国药品集中采购
证券之星 · 2025-10-30
中恒集团最新公告:控股子公司莱美药业产品尼可地尔片拟中选第十一批全国药品集中采购
每周股票复盘:中恒集团(600252)累计回购超2.91亿股
证券之星 · 2025-10-26
每周股票复盘:中恒集团(600252)累计回购超2.91亿股
股市必读:中恒集团(600252)10月21日披露最新机构调研信息
证券之星 · 2025-10-22
股市必读:中恒集团(600252)10月21日披露最新机构调研信息
每周股票复盘:中恒集团(600252)控股子公司获两项药品注册证
证券之星 · 2025-09-21
每周股票复盘:中恒集团(600252)控股子公司获两项药品注册证
每周股票复盘:中恒集团(600252)提名李骅为独董候选人
证券之星 · 2025-09-14
每周股票复盘:中恒集团(600252)提名李骅为独董候选人
每周股票复盘:中恒集团(600252)Q2净利增126.86%
证券之星 · 2025-08-31
每周股票复盘:中恒集团(600252)Q2净利增126.86%
中恒集团:2025年上半年净利润2707.76万元,同比增长23.59%
金融界 · 2025-08-29
中恒集团:2025年上半年净利润2707.76万元,同比增长23.59%
加载更多
公司概况
公司名称:
广西梧州中恒集团股份有限公司
所属行业:
医药制造业
上市日期:
2000-11-30
主营业务:
广西梧州中恒集团股份有限公司的主营业务是医药制造。公司的主要产品是心脑血管领域用药、骨骼肌肉领域用药、其他普药系列、特色专科类、大输液类、抗感染类、其他品种、药品销售服务、医药流通类、龟苓膏系列、龟苓宝系列、其他食品系列。中恒集团为国家高新技术企业,国家高新技术创新示范企业、国家知识产权示范企业,国家第二批先进制造业和现代服务业融合发展试点企业,位居中国医药工业百强、中华民族医药百强,具备领域优势和产品优势。
发行价格:
5.25
{"stockData":{"symbol":"600252","market":"SH","secType":"STK","nameCN":"中恒集团","latestPrice":2.77,"timestamp":1767942000000,"preClose":2.78,"halted":0,"volume":47576188,"delay":0,"changeRate":-0.0036,"floatShares":3184000000,"shares":3184000000,"eps":-0.1142,"marketStatus":"已收盘","change":-0.01,"latestTime":"01-09 15:00:00","open":2.77,"high":2.79,"low":2.74,"amount":132000000,"amplitude":0.018,"askPrice":2.78,"askSize":14850,"bidPrice":2.77,"bidSize":9671,"shortable":0,"etf":0,"ttmEps":-0.1142,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":5,"adr":0,"adjPreClose":2.78,"symbolType":"stock","openAndCloseTimeList":[[1767922200000,1767929400000],[1767934800000,1767942000000]],"highLimit":3.06,"lowLimit":2.5,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":3184163070,"isCdr":false,"pbRate":1.52,"roa":"--","roe":"0.4%","epsLYR":-0.1119,"committee":-0.176218,"marketValue":8820000000,"turnoverRate":0.0149,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-01-12。","floatMarketCap":8820000000},"requestUrl":"/m/hq/s/600252","defaultTab":"news","newsList":[{"id":"2602458535","title":"每周股票复盘:中恒集团(600252)获土地收储欠款727.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602458535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602458535?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:00","pubTimestamp":1768071633,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,中恒集团报收于2.77元,较上周的2.74元上涨1.09%。本周,中恒集团1月6日盘中最高价报2.84元。本周关注点来自公司公告汇总:中恒集团控股孙公司诉讼和解,706.82万元归属耀匀医药。来自公司公告汇总:中恒集团控股孙公司肇庆中恒制药收到土地收储欠款本息7,278,868.06元。广西梧州中恒集团股份有限公司控股孙公司肇庆中恒制药收到肇庆高新区土储中心支付的欠付款本金及利息7,278,868.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600252","BK0028","BK0077","BK0015","BK0012","BK0239"],"gpt_icon":0},{"id":"2601000626","title":"中恒集团(600252)披露为控股子公司中恒中药材提供担保公告,1月5日股价上涨1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601000626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601000626?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:17","pubTimestamp":1767608259,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,中恒集团报收于2.77元,较前一交易日上涨1.09%,最新总市值为88.2亿元。近日,广西梧州中恒集团股份有限公司发布公告称,公司为控股子公司广西中恒中药材产业发展有限公司向交通银行梧州分行申请融资提供最高额999.9852万元的连带责任保证担保。中恒中药材为公司控股子公司,公司直接和间接合计持股100%,其2025年前三季度资产总额14,513.78万元,净利润41.43万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500028297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0239","BK0015","BK0077","BK0028","600252"],"gpt_icon":0},{"id":"2600036476","title":"每周股票复盘:中恒集团(600252)拟清算医药投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036476","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036476?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:18","pubTimestamp":1767295092,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,中恒集团报收于2.78元,较上周的2.89元下跌3.81%。公司公告汇总广西梧州中恒集团股份有限公司第十届董事会第三十五次会议于2025年12月29日召开,审议通过关于清算注销广西力合中恒医药投资合伙企业的议案,同意依法进行清算并注销该合伙企业。广西梧州中恒集团股份有限公司2025年第三次临时股东大会于2025年12月29日召开,审议通过取消监事会并修订公司章程、续聘2025年度会计师事务所、提名第十届董事会董事候选人等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","BK0077","BK0012","600252","BK0239","BK1515","BK0028","BK1574","159938","BK1161","09939","BK0188"],"gpt_icon":0},{"id":"2595937775","title":"中恒集团:为控股子公司提供近1000万元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2595937775","media":"视频滚动新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595937775?lang=zh_cn&edition=full","pubTime":"2025-12-31 18:58","pubTimestamp":1767178680,"startTime":"0","endTime":"0","summary":"中恒集团公告称,为满足控股子公司中恒中药材经营需求,2025年12月31日,公司与交通银行梧州分行签订《保证合同》,为中恒中药材提供最高999.9852万元连带责任保证担保,无反担保。公司直接和间接持有中恒中药材100%股份。截至公告日,公司及子公司对外担保总额2.54亿元,占2024年经审计归母净资产的4.22%,无逾期担保事项。本次担保在已获批的综合授信额度内,无需再履行审议程序。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:小浪快报","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/videoroll/2025-12-31/doc-inhesxnh9001213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600252","BK0028","BK0188","BK0077","BK0015","BK0012","BK0239"],"gpt_icon":0},{"id":"2595720747","title":"中恒集团(600252)披露关于变更持续督导财务顾问主办人的公告,12月31日股价上涨0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595720747","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595720747?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:47","pubTimestamp":1767174454,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,中恒集团报收于2.74元,较前一交易日上涨0.37%,最新总市值为87.25亿元。公司近日发布公告称,2025年12月29日,中恒集团收到国海证券通知,原持续督导财务顾问主办人汪毅之因个人原因离职,不再履行相关职责。国海证券已委派朱原锋接替其职务,继续履行广西投资集团金融控股有限公司及其一致行动人免于发出要约收购中恒集团的持续督导责任。本次变更后,持续督导主办人为周琢和朱原锋。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100032807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0028","BK0012","600252","BK0015","BK0239"],"gpt_icon":0},{"id":"2594242227","title":"每周股票复盘:中恒集团(600252)拟注销1106.53万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2594242227","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594242227?lang=zh_cn&edition=full","pubTime":"2025-12-28 04:20","pubTimestamp":1766866818,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:中恒集团因2024年业绩未达标及激励对象变动,拟回购注销11,065,300股限制性股票。广西梧州中恒集团股份有限公司发布公告称,因2024年度业绩未达股权激励计划第三个解除限售期考核要求,且有204名激励对象因个人原因退出、7名激励对象不再具备激励资格,公司将回购注销11,065,300股限制性股票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0188","BK0077","BK0239","BK0028","BK0015","600252"],"gpt_icon":0},{"id":"2593641526","title":"中恒集团(600252)披露为控股子公司田七家化提供担保,12月23日股价下跌1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593641526","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593641526?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:26","pubTimestamp":1766500013,"startTime":"0","endTime":"0","summary":"近日,广西梧州中恒集团股份有限公司发布公告称,公司为控股子公司广西田七家化实业有限公司向中国民生银行股份有限公司南宁分行申请融资提供最高额554.426万元的连带责任保证担保,保证期间为债务履行期限届满日起三年。田七家化为公司持股55.4426%的控股子公司,截至公告日,公司及其控股子公司对外担保余额为31,926.42万元,占公司2024年经审计净资产的5.30%,无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300040461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0028","BK0012","600252","BK0015","BK0239"],"gpt_icon":0},{"id":"2593648540","title":"中恒集团(600252)披露股权激励限制性股票回购注销实施公告,12月22日股价下跌0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593648540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593648540?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:52","pubTimestamp":1766397173,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘,中恒集团报收于2.87元,较前一交易日下跌0.69%,最新总市值为91.7亿元。本次回购注销已获董事会、监事会及股东大会审议通过,并已完成通知债权人程序。回购股份将于2025年12月24日完成注销,注销后公司总股本相应减少,不再存在限制性股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200022565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","BK0028","BK0188","BK0239","BK0012","600252","BK0077"],"gpt_icon":0},{"id":"2590867205","title":"中恒集团最新公告:控股孙公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2590867205","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590867205?lang=zh_cn&edition=full","pubTime":"2025-12-10 19:03","pubTimestamp":1765364590,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称,公司控股子公司重庆莱美药业之子公司海南莱美医疗器械有限公司近日收到海南省药品监督管理局颁发的两项《医疗器械注册证》,分别是医用电子内窥镜图像处理器和电子支气管镜,有效期均为2025年11月17日至2030年11月16日。该产品能直接观察患者图像,有利于临床使用对患者病症的判断及治疗。此次产品获证将进一步丰富公司医疗器械产品种类,满足市场多样化的需求,提升公司综合竞争力,对未来经营将产生积极影响。为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251210/31856961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1100","BK1574","BK0077","BK0012","600252","BK0188","BK0028","BK0015","BK1222","09996","BK1583","09997","159883","BK0239"],"gpt_icon":0},{"id":"2588237880","title":"中恒集团(600252)披露控股孙公司获得药物临床试验批准通知书,12月04日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588237880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588237880?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:22","pubTimestamp":1764858145,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘,中恒集团报收于2.98元,较前一交易日下跌1.0%,最新总市值为95.22亿元。近日,广西梧州中恒集团股份有限公司发布公告称,其控股孙公司四川瀛瑞医药科技有限公司自主研发的创新抗癌药物“纳米炭铁混悬注射液”获国家药品监督管理局批准,同意其联合标准放疗在实体瘤患者中开展临床试验。该药物为新一代纳米药物,通过调控铁死亡通路发挥抗癌作用,目前二期临床试验进展顺利,已累计投入研发费用9,428.26万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400039669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600252","BK0015","BK0188","BK0028","BK0239","BK0012"],"gpt_icon":0},{"id":"2588888323","title":"中恒集团最新公告:控股孙公司纳米炭铁混悬注射液药物临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2588888323","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588888323?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:59","pubTimestamp":1764842378,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称,近日,公司控股子公司重庆莱美药业股份有限公司之子公司四川瀛瑞医药科技有限公司自主研发的创新抗癌药物“纳米炭铁混悬注射液”获国家药监局签发《药物临床试验批准通知书》,同意该药品联合标准放疗在实体瘤患者中开展临床试验。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400028283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0188","BK0077","BK0239","BK0028","BK0015","600252"],"gpt_icon":0},{"id":"2586286416","title":"异动快报:中恒集团(600252)11月26日9点49分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2586286416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586286416?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:50","pubTimestamp":1764121834,"startTime":"0","endTime":"0","summary":"证券之星11月26日盘中消息,9点49分中恒集团触及涨停板。其所属行业中药目前上涨。领涨股为粤万年青。该股为医药,中药,广西概念概念热股,当日医药概念上涨1.77%,中药概念上涨1.74%,广西概念概念上涨0.65%。11月25日的资金流向数据方面,主力资金净流入625.72万元,占总成交额5.58%,游资资金净流入472.78万元,占总成交额4.22%,散户资金净流出1098.5万元,占总成交额9.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600006640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600252","BK0015","BK0188","BK0028","BK0239","BK0012"],"gpt_icon":0},{"id":"2580142394","title":"中恒集团(600252)2025年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2580142394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580142394?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:06","pubTimestamp":1761948392,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期中恒集团发布2025年三季报。根据财报显示,中恒集团营收净利润同比双双增长。截至本报告期末,公司营业总收入19.48亿元,同比上升1.1%,归母净利润2464.04万元,同比上升119.61%。按单季度数据看,第三季度营业总收入4.97亿元,同比下降3.65%,第三季度归母净利润-243.72万元,同比上升77.2%。本次财报公布的各项数据指标表现一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100005313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252"],"gpt_icon":0},{"id":"2579110363","title":"中恒集团最新公告:控股子公司莱美药业产品尼可地尔片拟中选第十一批全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2579110363","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579110363?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:02","pubTimestamp":1761822123,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称,公司控股子公司莱美药业参加了第十一批全国药品集中采购并拟中选尼可地尔片,该产品尚未开展销售。若后续签订采购合同并实施,将促进产品销售和市场拓展,提升公司品牌影响力,对长远发展有积极影响。但中标结果和采购合同签订存在不确定性,且药品生产和销售受多种因素影响,投资者需谨慎决策并注意投资风险。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000039276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252","BK0070","BK0028","BK0015","BK0077","BK0012","BK0239","BK0188","300006"],"gpt_icon":0},{"id":"2578792502","title":"每周股票复盘:中恒集团(600252)累计回购超2.91亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2578792502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578792502?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:28","pubTimestamp":1761420492,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,中恒集团报收于2.8元,较上周的2.78元上涨0.72%。本周,中恒集团10月22日盘中最高价报2.87元。10月20日盘中最低价报2.77元。中恒集团当前最新总市值89.47亿元,在中药板块市值排名28/67,在两市A股市值排名2060/5160。截至目前,公司已累计实施3次股份购,共购股份超2.91亿股,并已全部完成注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0015","600252","BK0239","BK0012","BK0077","BK0188"],"gpt_icon":0},{"id":"2577680801","title":"股市必读:中恒集团(600252)10月21日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2577680801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577680801?lang=zh_cn&edition=full","pubTime":"2025-10-22 01:26","pubTimestamp":1761067569,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘,中恒集团报收于2.85元,上涨1.79%,换手率1.79%,成交量57.04万手,成交额1.61亿元。中恒集团围绕心脑血管及慢性病领域,2024年立项4个中药创新药和1个化药创新药,2025年积极引进化药1类新药“一种治疗慢性心力衰竭的药物”,开展3个中药3类新药经典名方的中试研究,推动中药1类新药“三芪颗粒”获得临床试验批准通知书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200000945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","BK0239","BK0188","BK0015","600252","BK0077"],"gpt_icon":0},{"id":"2569245088","title":"每周股票复盘:中恒集团(600252)控股子公司获两项药品注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2569245088","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569245088?lang=zh_cn&edition=full","pubTime":"2025-09-21 03:48","pubTimestamp":1758397695,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘,中恒集团报收于2.83元,较上周的2.77元上涨2.17%。本周关注点公司公告汇总:控股子公司莱美药业获得尼可地尔片和酮咯酸氨丁三醇注射液药品注册证书。广西梧州中恒集团股份有限公司拟回购注销11,065,300股限制性股票,其中因2024年度业绩未达标涉及4名激励对象102,000股,因204名激励对象自愿退出及7名不再具备激励条件合计10,963,300股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0015","BK0077","BK0028","BK0188","600252","BK0239"],"gpt_icon":0},{"id":"2567357711","title":"每周股票复盘:中恒集团(600252)提名李骅为独董候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2567357711","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567357711?lang=zh_cn&edition=full","pubTime":"2025-09-14 04:15","pubTimestamp":1757794514,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘,中恒集团报收于2.77元,较上周的2.72元上涨1.84%。本周关注点公司公告汇总:中恒集团提名李骅为独立董事候选人,接替任职期满的李俊华。公司公告汇总广西梧州中恒集团股份有限公司于2025年9月12日召开第十届董事会第三十一次会议,审议通过提名李骅先生为公司第十届董事会独立董事候选人。该提名议案需提交股东大会审议,且候选人任职资格须经上海证券交易所审核无异议后,方可提交表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400000953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0015","BK0028","BK0012","600252","BK0239"],"gpt_icon":0},{"id":"2563837819","title":"每周股票复盘:中恒集团(600252)Q2净利增126.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563837819","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563837819?lang=zh_cn&edition=full","pubTime":"2025-08-31 15:37","pubTimestamp":1756625828,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘,中恒集团报收于2.73元,较上周的2.88元下跌5.21%。股本股东变化截至2025年6月30日,中恒集团股东户数为11.49万户,较3月31日减少7,404户,减幅6.05%。业绩披露要点中恒集团2025年中报显示,主营收入14.51亿元,同比上升2.84%;归母净利润2,707.76万元,同比上升23.59%;扣非净利润2,483.02万元,同比上升196.24%。回购股份将于2025年8月27日注销,总股本由3,313,345,567股减少至3,195,228,370股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100005100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252","BK0028","BK0239","BK0012","BK0015","BK0188","BK0077"],"gpt_icon":0},{"id":"2563021040","title":"中恒集团:2025年上半年净利润2707.76万元,同比增长23.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563021040","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563021040?lang=zh_cn&edition=full","pubTime":"2025-08-29 22:11","pubTimestamp":1756476689,"startTime":"0","endTime":"0","summary":"中恒集团公告,2025年上半年营业收入14.51亿元,同比增长2.84%。净利润2707.76万元,同比增长23.59%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/29221152819296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600252"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768084329021,"stockEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":-0.0246},{"period":"3month","weight":0.0036},{"period":"6month","weight":0.0336},{"period":"1year","weight":0.1888},{"period":"ytd","weight":0.0109}],"compareEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.0564},{"period":"3month","weight":0.0573},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广西梧州中恒集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"118959人(较上一季度增加3.54%)","perCapita":"26766股","listingDate":"2000-11-30","address":"广西壮族自治区梧州市万秀区工业园区工业大道1号第1幢","registeredCapital":"318416万元","survey":" 广西梧州中恒集团股份有限公司的主营业务是医药制造。公司的主要产品是心脑血管领域用药、骨骼肌肉领域用药、其他普药系列、特色专科类、大输液类、抗感染类、其他品种、药品销售服务、医药流通类、龟苓膏系列、龟苓宝系列、其他食品系列。中恒集团为国家高新技术企业,国家高新技术创新示范企业、国家知识产权示范企业,国家第二批先进制造业和现代服务业融合发展试点企业,位居中国医药工业百强、中华民族医药百强,具备领域优势和产品优势。","listedPrice":5.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中恒集团(600252)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中恒集团(600252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中恒集团,600252,中恒集团股票,中恒集团股票老虎,中恒集团股票老虎国际,中恒集团行情,中恒集团股票行情,中恒集团股价,中恒集团股市,中恒集团股票价格,中恒集团股票交易,中恒集团股票购买,中恒集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中恒集团(600252)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中恒集团(600252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}